These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28385577)

  • 21. Mutagenicity assessment of two potential impurities in preparations of 5-amino-2,4,6 triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol.
    Rossi S; Bussi S; Bonafè R; Incardona C; Vurro E; Visigalli M; Buonsanti F; Fretta R
    Mutat Res Genet Toxicol Environ Mutagen; 2024 Jan; 893():503720. PubMed ID: 38272634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.
    Honma M; Kitazawa A; Cayley A; Williams RV; Barber C; Hanser T; Saiakhov R; Chakravarti S; Myatt GJ; Cross KP; Benfenati E; Raitano G; Mekenyan O; Petkov P; Bossa C; Benigni R; Battistelli CL; Giuliani A; Tcheremenskaia O; DeMeo C; Norinder U; Koga H; Jose C; Jeliazkova N; Kochev N; Paskaleva V; Yang C; Daga PR; Clark RD; Rathman J
    Mutagenesis; 2019 Mar; 34(1):3-16. PubMed ID: 30357358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
    Contrera JF
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.
    Jolly R; Ahmed KB; Zwickl C; Watson I; Gombar V
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):388-97. PubMed ID: 25656493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing between expert and statistical systems for application under ICH M7.
    Barber C; Hanser T; Judson P; Williams R
    Regul Toxicol Pharmacol; 2017 Mar; 84():124-130. PubMed ID: 28057482
    [No Abstract]   [Full Text] [Related]  

  • 27. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
    Amberg A; Anger LT; Bercu J; Bower D; Cross KP; Custer L; Harvey JS; Hasselgren C; Honma M; Johnson C; Jolly R; Kenyon MO; Kruhlak NL; Leavitt P; Quigley DP; Miller S; Snodin D; Stavitskaya L; Teasdale A; Trejo-Martin A; White AT; Wichard J; Myatt GJ
    Mutagenesis; 2019 Mar; 34(1):67-82. PubMed ID: 30189015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates.
    Hasselgren C; Bercu J; Cayley A; Cross K; Glowienke S; Kruhlak N; Muster W; Nicolette J; Reddy MV; Saiakhov R; Dobo K
    Regul Toxicol Pharmacol; 2020 Dec; 118():104807. PubMed ID: 33058939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology.
    Cariello NF; Wilson JD; Britt BH; Wedd DJ; Burlinson B; Gombar V
    Mutagenesis; 2002 Jul; 17(4):321-9. PubMed ID: 12110629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It's difficult, but important, to make negative predictions.
    Williams RV; Amberg A; Brigo A; Coquin L; Giddings A; Glowienke S; Greene N; Jolly R; Kemper R; O'Leary-Steele C; Parenty A; Spirkl HP; Stalford SA; Weiner SK; Wichard J
    Regul Toxicol Pharmacol; 2016 Apr; 76():79-86. PubMed ID: 26785392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapolation of in vitro structural alerts for mutagenicity to the in vivo endpoint.
    Tennant RE; Guesné SJ; Canipa S; Cayley A; Drewe WC; Honma M; Masumura K; Morita T; Stalford SA; Williams RV
    Mutagenesis; 2019 Mar; 34(1):111-121. PubMed ID: 30281100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical application of two in silico systems for identification of potentially mutagenic impurities.
    Greene N; Dobo KL; Kenyon MO; Cheung J; Munzner J; Sobol Z; Sluggett G; Zelesky T; Sutter A; Wichard J
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):335-49. PubMed ID: 25980641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico prediction of genotoxicity.
    Wichard JD
    Food Chem Toxicol; 2017 Aug; 106(Pt B):595-599. PubMed ID: 27979779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.
    Barber C; Cayley A; Hanser T; Harding A; Heghes C; Vessey JD; Werner S; Weiner SK; Wichard J; Giddings A; Glowienke S; Parenty A; Brigo A; Spirkl HP; Amberg A; Kemper R; Greene N
    Regul Toxicol Pharmacol; 2016 Apr; 76():7-20. PubMed ID: 26708083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.
    Coppi A; Davies R; Wegesser T; Ishida K; Karmel J; Han J; Aiello F; Xie Y; Corbett MT; Parsons AT; Monticello TM; Minocherhomji S
    Regul Toxicol Pharmacol; 2022 Jun; 131():105162. PubMed ID: 35331777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: Risk assessment of potentially mutagenic impurities.
    Waechter F; Falcao Oliveira AA; Borges Shimada AL; Bernes Junior E; de Souza Nascimento E
    Regul Toxicol Pharmacol; 2024 Aug; 151():105669. PubMed ID: 38936796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test.
    Nicolette J; Neft RE; Vanosdol J; Murray J
    Environ Mol Mutagen; 2016 Apr; 57(3):236-40. PubMed ID: 26840011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico prediction of chromosome damage: comparison of three (Q)SAR models.
    Morita T; Shigeta Y; Kawamura T; Fujita Y; Honda H; Honma M
    Mutagenesis; 2019 Mar; 34(1):91-100. PubMed ID: 30085209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.